Abstract
The RFID business is growing so fast that few applicational sectors can beat
that scorching rate of growth. Healthcare and pharmaceuticals is one of them
thanks to the new tagging of drugs, real time location of staff and patients
and other developments including automated error prevention. This unique
report gives a full technical and market analysis illustrated by 70 case
studies. It is a vital resource for the healthcare profession and all who wish
to support it. We separately assess the opportunity for both passive and
active tags in pharmaceuticals and healthcare in the following sectors:
- Pharmaceutial drugs
- Medical disposables and other items
- Pallets and cases
- Laundry
- People
- Secure Access
- Conveyances, vehicles, assets
- Real Time Locating Systems (RTLS)
- Sensor based applications
RFID in healthcare and pharmaceuticals has special requirements,
unquantifiable benefits (safety, security, reputation, brand protection etc)
and sometimes tolerance of longer paybacks for such reasons can often lead to
very profitable and worthwhile business for suppliers. Extensive benchmarking
in the business leads to rapid dissemination of the multiple benefits to users
of given schemes and great pressure on the laggards to catch up. Rapid
increase in adoption The market for RFID tags and systems in healthcare will
rise rapidly from $120.9 million in 2008 to $2.03 billion in 2018. Primarily,
this will be because of item level tagging of drugs and Real Time Locating
Systems (RTLS) for staff, patients and assets to improve efficiency, safety
and availability and to reduce losses. The tagging of the packs of
blisterpacks and the plastic bottles used by patients is primarily a US
phenomenon driven by the need for improved anticounterfeiting but there will
be great improvements in theft deterrence and improved stock control and
recalls.
This report analyses 10 year forecasts of RFID in the healthcare and
pharmaceutical sector.
Report Statistics
- Pages :285
- Tables Over :45
- Figures Over :100
- Case Studies Over :70
- Forecasts to :2018
- Last update :Q2 2018